奥拉帕利加贝伐单抗一线维持治疗卵巢癌：来自PAOLA-1/ENGOT-ov25试验的最终总体生存结果

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer2021 · 92 citations
2. 2European Network of Gynaecological Oncological Trial Groups’ Requirements for Trials Between Academic Groups and Pharmaceutical Companies2010 · 47 citations
3. 3201 Homologous recombination deficiency testing in advanced ovarian cancer: description of the ENGOT HRD European initiative2021 · 18 citations
4. 4Risk of Leukemia after Platinum-Based Chemotherapy for Ovarian Cancer1999 · 359 citations
5. 5Late relapse of epithelial ovarian cancer: a single institution experience.2005 · 5 citations